NasdaqCM - Nasdaq Real Time Price USD

TC Biopharm (Holdings) Plc (TCBP)

Compare
0.6086 -0.0212 (-3.37%)
As of 12:56 PM EST. Market Open.
Currency in GBP All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
3,844.5320
1,978.6590
1,978.6590
Operating Expense
13,515.2140
14,239.3230
15,928.5290
9,259.3020
8,317.4700
Operating Income
-13,515.2140
-14,239.3230
-12,083.9970
-7,280.6430
-6,338.8110
Net Non Operating Interest Income Expense
--
-83.0250
-6,753.2310
-3,438.5150
-291.0330
Other Income Expense
4,204.8720
7,326.6660
15,803.6270
-4,264.3090
--
Pretax Income
-9,393.3670
-6,995.6820
-3,033.6010
-14,983.4670
-6,629.8440
Tax Provision
-799.4710
-1,088.7290
-1,720.0000
-1,407.5420
-1,171.9280
Net Income Common Stockholders
-8,593.8960
-5,906.9530
-1,313.6010
-13,575.9250
-5,457.9160
Diluted NI Available to Com Stockholders
-8,593.8960
-5,906.9530
-1,313.6010
-13,575.9250
-5,457.9160
Basic EPS
-15.20
-19.20
-38.20
-694.49
-194.52
Diluted EPS
-15.20
-19.20
-38.20
-694.49
-194.52
Basic Average Shares
660.0060
308.9210
34.3600
19.5480
28.0580
Diluted Average Shares
660.0060
308.9210
34.3600
19.5480
28.0580
Total Operating Income as Reported
-13,515.2140
-14,239.3230
-12,083.9970
--
--
Total Expenses
13,515.2140
14,239.3230
15,928.5290
9,259.3020
8,317.4700
Net Income from Continuing & Discontinued Operation
-8,593.8960
-5,906.9530
-1,313.6010
-13,575.9250
-5,457.9160
Normalized Income
-13,017.6711
-12,638.7124
-14,228.2175
-9,712.2038
-5,457.9160
Interest Income
--
--
2.2080
0.0330
1.0290
Interest Expense
--
83.0250
6,753.2310
3,438.5480
292.0620
Net Interest Income
--
-83.0250
-6,753.2310
-3,438.5150
-291.0330
EBIT
-6,188.5480
-6,912.6570
3,719.6300
-11,544.9190
-6,337.7820
EBITDA
-5,609.4890
-6,279.6490
4,489.2260
-10,519.8610
-5,262.5670
Reconciled Depreciation
579.0590
633.0080
769.5960
1,025.0580
1,075.2150
Net Income from Continuing Operation Net Minority Interest
-8,593.8960
-5,906.9530
-1,313.6010
-13,575.9250
-5,457.9160
Total Unusual Items Excluding Goodwill
4,835.3090
7,972.5110
15,943.9710
-4,264.3090
--
Total Unusual Items
4,835.3090
7,972.5110
15,943.9710
-4,264.3090
--
Normalized EBITDA
-10,444.7980
-14,252.1600
-11,454.7450
-6,255.5520
-5,262.5670
Tax Rate for Calcs
0.0001
0.0002
0.0002
0.0001
0.0002
Tax Effect of Unusual Items
411.5339
1,240.7516
3,029.3545
-400.5878
--
12/31/2020 - 2/11/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers